News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: January 24, 2024
The response with the pump is “clearly superior” to systemic treatment, according to the author a new study.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: January 23, 2024
The findings of a new study indicate that nivolumab plus ipilimumab should really be “a new standard,” a medical oncologist says.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: January 19, 2024
Over the past decade, radiation oncologists have seen a 23% drop in Medicare reimbursement for Read More
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: January 12, 2024
Zolbetuximab was under priority review as the first agent specifically for locally advanced unresectable or metastatic HER2-negative...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: January 5, 2024
Paramagnetic seeds work just as well as standard guidewires and are easier to use.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: December 18, 2023
Although pregnancy after breast cancer is considered safe in general, little data exist for BRCA carriers.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: December 12, 2023
Using a gene test to guide radiation decisions may reduce overtreatment in ductal carcinoma in situ.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: December 7, 2023
“Based on the data, it’s a reasonable conclusion that radiotherapy can be avoided.”
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: December 1, 2023
“This guidance document aims to support clinicians, as they navigate the complexities of treatment planning amid the drug shortage.”
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: November 29, 2023
Efbemalenograstim has been approved by the FDA to combat infections in adults being treated for nonmyeloid cancers.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: November 21, 2023
“This case series shows that rectal cancer is increasingly being managed medically,” the authors said.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: November 8, 2023
These results also “suggest that vitamin D supplementation in patients with lower levels of vitamin D may reduce peripheral neuropathy ...”
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: November 2, 2023
This validation study confirms that the Immunoscore biopsy “is an independent parameter predicting time to recurrence” and can help physicians and ...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: November 2, 2023
The outcome, some community oncologists say, could set a new precedent in how far large health care organizations will go to take their patients or...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: October 25, 2023
For adults with a rare form of myelodysplastic syndromes, the FDA has approved a targeted therapy called ivosidenib.
